HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats.

Abstract
Given that adult adipose tissue is an abundant, accessible and safe source of stem cells, the use of adipose-derived stem cells (ADSCs) provides a promising approach in ischemic stroke. The delivery route, however, for transplantation of ADSCs in clinical application remains controversial regarding the time window, cell type, safety issues, 'first pass' effect and therapeutic effect. To determine the optimal administration route in transplantation of ADSCs, we compared the therapeutic effect of the three mainly used administration routes of ADSCs in a middle cerebral artery occlusion (MCAO) rat model. Cells isolated from the adipose tissue of adult rodents were differentiated and characterized in vitro, and further transplanted in vivo by intravenous, intra-arterial or intra-ventricular delivery. The infarct volume, expression of neurotrophic factors and the neurobehavioral improvements were evaluated after the equal dose of BrdU labeled ADSCs transplantation. Our results indicated that the equal dose of ADSCs delivered intravenously were effective in improving the neurological outcome and reducing the infarct volume after ischemic brain injury in long term duration in contrast to intra-arterial and intra-ventricular delivery. At 1-7 days after transplantation, the increased expression levels of BDNF, VEGF, bFGF, Bcl-2, IL-10 and decreased levels of caspase-3 and TNF-α in the intra-ventricular and intra-arterial groups were significant in contrast to the intravenous group. There was no significant difference among the three groups after 7 days. Our findings suggest that compared with the intra-ventricular delivery, intravascular injection allows higher dose injection with fewer invasions and appears to be optimal in application with regard to therapeutic efficacy, safety and feasibility.
AuthorsGuojia Du, Yao Liu, Muren Dang, Guohua Zhu, Riqing Su, Yandong Fan, Zeming Tan, Li Xin Wang, Jiasheng Fang
JournalActa histochemica (Acta Histochem) Vol. 116 Issue 6 Pg. 1075-84 (Jul 2014) ISSN: 1618-0372 [Electronic] Germany
PMID24962764 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier GmbH. All rights reserved.
Chemical References
  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • Proto-Oncogene Proteins c-bcl-2
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Fibroblast Growth Factor 2
  • Interleukin-10
Topics
  • Adipogenesis
  • Administration, Intravenous
  • Adult Stem Cells (transplantation)
  • Animals
  • Biomarkers (metabolism)
  • Brain-Derived Neurotrophic Factor (genetics, metabolism)
  • Cell Shape
  • Cells, Cultured
  • Fibroblast Growth Factor 2 (genetics, metabolism)
  • Gene Expression
  • Infarction, Middle Cerebral Artery (pathology, therapy)
  • Injections, Intra-Arterial
  • Injections, Intraventricular
  • Interleukin-10 (genetics, metabolism)
  • Male
  • Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
  • Rats, Sprague-Dawley
  • Subcutaneous Fat (cytology)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: